IMS Health Holdings Inc

IMS Health — Q1 2016 Earnings Presentation

17 slides from IMS Health's earnings presentation, May 3, 2016

  1. Slide 1: IMS Health Q1 2016 Earnings Call

    IMS Health Q1 2016 Earnings Call May 3, 2016 0

  2. Slide 2: Legal

    Legal This presentation should be viewed in conjunction with IMS Health’s Q1 2016 earnings call Safe Harbor Statement This presentation Thi t ti includes i l d “forward-looking “f d l ki statements”, t t t ” including i l di statements t t t regarding di future f t fi financial i l and d operating t

  3. Slide 3: 1st Quarter Results

    1st Quarter Results $M Revenue Adjusted EBITDA +25.2% 25 2% +9.4% 9 4% @ CFx @ CFx $774 $236 $216 $632 Q1 2016 Q1 2015 Q1 2016 Q1 2015 Note: Dollars are at actual foreign exchange rates. CFx is constant currency. EBITDA is “Adjusted EBITDA” as calculated in the appendix of this presentation 2

  4. Slide 4: 1st Quarter Offering Revenue

    1st Quarter Offering Revenue Offering 1st Quarter Versus Prior Year Constant $M 2016 2015 Reported Currency Information $376 $354 9.0% 6.0% Technology Services $398 $278 45.8% 43.6% Total $774 $632 25.2% 22.5% Note: Dollars are at actual foreign exchange rates 3

  5. Slide 5: 1st Quarter Geographic Revenue

    1st Quarter Geographic Revenue Geography 1st Quarter Versus Prior Year Constant $M 2016 2015 Reported Currency Developed Markets $650 $527 24.7% 23.3% Emerging Markets $124 $105 28.1% 18.3% Total $774 $632 25.2% 22.5% Note: Dollars are at actual foreign exchange rates Prior year adjusted to conform

  6. Slide 6: 1st Quarter EBITDA

    1st Quarter EBITDA 1st Quarter Versus Prior Year Constant $M 2016 2015 Reported Currency Adjusted EBITDA (1) $236 $216 9.4% 9.3% Adjusted EBITDA margin 30.5% 34.2% (435) bps (370) bps Note: Dollars are at actual foreign exchange rates (1) See reconciliations of non-GAAP items in appendix 5

  7. Slide 7: 1st Quarter P&L

    1st Quarter P&L At reported FX rates $M (except per share data) 2016 2015 Net Income $43 $298 Diluted Earnings per Share $0.13 $0.86 Adjusted Net Income (1) $140 $136 Adjusted Diluted Earnings per Share (1) $0.42 $0.39 (1) See reconciliations of non-GAAP items in appendix 6

  8. Slide 8: 1st Quarter Balance Sheet Items & Metrics

    1st Quarter Balance Sheet Items & Metrics $M 2016 2015 Cash & Cash Equivalents $378 $396 (1) p Balance of Debt (2) Principal $4,606 $ , $4,266 $ , (1) Net Debt $4,228 $3,870 (1) Gross Leverage Ratio 5.1x 4.8x (1) Net Cash (Used in) Provided by Operating Activities ($15) $30 Capital Expenditures and

  9. Slide 9: Full-Year 2016 Guidance

    Full-Year 2016 Guidance Full-Year 2016 Revenue Growth Constant Currency 10 – 12% Reported (1) 9 – 11% Adjusted EBITDA Growth Constant Currency 7.5 – 9.5% Reported (1) 7.5 – 9.5% Adjusted Net Income Growth Constant Currency 6.5 – 8.5% Reported (1) 2 – 4% Adjusted Diluted EPS Constant Currency 8.5 – 1

  10. Slide 10: Q2 2016 Guidance

    Q2 2016 Guidance Q2 2016 Revenue Growth Constant Currency 7.5 – 8.5% Reported (1) 7.5 – 8.5% Adjusted EBITDA Growth Constant Currency 5 – 6% Reported (1) 6.5 – 7.5% Adjusted Net Income Growth Constant Currency 4.5 – 5.5% Reported (1) 1 – 2% Adjusted Diluted EPS Constant Currency 5.5 – 6.5% Reported

  11. Slide 11: Q&A

    Q&A 10

  12. Slide 12: Appendix: Non-GAAP Financial Measures

    Appendix: A di Non-GAAP N GAAP Financial Measures 11

  13. Slide 13: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA Three Months Ended March 31, (in millions) 2016 2015 Net Income $ 43 $ 298 Provision for (benefit from) income taxes 20 (240) Other (income) loss, net 5 (4) Interest expense 46 37 Interest income (1) — Depreciation and amortization 87 96 D f Deferredd revenue purchase h

  14. Slide 14: Net Income to Adjusted Net Income & Per Share Data

    Net Income to Adjusted Net Income & Per Share Data Three Months Ended March 31, (in millions, except per share data) 2016 2015 Net Income $ 43 $ 298 Provision for (benefit from) income taxes 20 (240) A Amortization ti ti associated i t d with ith purchase h accounting ti 53 62 Deferred revenue purch

  15. Slide 15: Unlevered Free Cash Flow

    Unlevered Free Cash Flow Three Months Ended March 31, 31 (in millions) 2016 2015 Net Cash (Used in) Provided by Operating Activities $ (15) $ 30 Capital expenditures (13) (9) Additions to computer software (26) (23) Free Cash Flow $ (54) $ (2) Cash interest ppayments y 33 30 Cash tax payments, net o

  16. Slide 16: Gross Leverage Ratio

    Gross Leverage Ratio (in millions) Gross Debt as of March 31, 2016 $ 4,606 Adjusted EBITDA for the year ended December 31, 2015 886 Less: Adjusted j EBITDA for the three months ended March 31, 2015 (216) Add: Adjusted EBITDA for the three months ended March 31, 2016 236 Adjusted EBITDA for the twelv

  17. Slide 17: Non-GAAP Adjustments By Income Statement Line Items

    Non-GAAP Adjustments By Income Statement Line Items Three Months Ended March 31, (in millions) 2016 2015 Non-GAAP adjustments included in: Operating costs of information, exclusive of depreciation and amortization 1 1 Di Directt and d incremental i t l costs t off technology t h l services, i exclus

IMS Health — Q1 2016 Earnings Presentation on 6ix